Targeted treatment for depression could benefit patients with psychosis

Patients with early onset psychosis may benefit from treatment for depression, including with anti-depressants alongside other medication, new research shows. According to scientists at the University of Birmingham’s Institute for Mental Health – part of BHP – depression may be an intrinsic part of early phase psychotic disorders that should be treated together with other  more prominent … Continue reading “Targeted treatment for depression could benefit patients with psychosis”

Why I’m taking part in a COVID-19 vaccine trial – Josh’s Story

I’ve been asking people to take part in clinical research for years. Last month, it was my turn to be asked. My name’s Josh and I work for West Midlands Ambulance Service University NHS Foundation Trust as a research paramedic. I’ve been in the job since 2016 and love it! The work is very varied, and one … Continue reading “Why I’m taking part in a COVID-19 vaccine trial – Josh’s Story”

New approach boosts recruitment to critical trauma trial

A UK trial into the effectiveness of giving blood to trauma patients before they come to hospital has recently introduced an innovation that, if proven to be successful, could be adopted across the country. Previously, only doctors could recruit patients to the RePHILL (Resuscitation with Pre-Hospital Blood Products) trial. To The RePHILL team have developed … Continue reading “New approach boosts recruitment to critical trauma trial”

Regulation matters: BHP expert appointed to UK’s new Regulatory Horizon Council

Professor Alastair Denniston, Lead for Artificial Intelligence in Healthcare at Birmingham Health Partners’ Centre for Regulatory Science and Innovation, has been appointed to the UK government’s new Regulatory Horizon Council. The Council is a government-backed, independent expert committee, established to ensure that UK regulation keeps pace with innovation and enables it to thrive while safeguarding … Continue reading “Regulation matters: BHP expert appointed to UK’s new Regulatory Horizon Council”

Newly-discovered gut enzyme could be disease biomarker

Enzymes used by bacteria to break down mucus in the gut could provide a useful biomarker for intestinal diseases, according to new research published in Nature Communications. Researchers at BHP founder-member the University of Birmingham, working with colleagues at Newcastle University, have successfully identified and characterised one of the key enzymes involved in this process. … Continue reading “Newly-discovered gut enzyme could be disease biomarker”